Antibiotice S.A. (ATB.RO)
- Previous Close
1.9600 - Open
1.9600 - Bid 1.9900 x --
- Ask 1.9950 x --
- Day's Range
1.9600 - 1.9950 - 52 Week Range
0.5980 - 2.0100 - Volume
169,613 - Avg. Volume
200,145 - Market Cap (intraday)
1.336B - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
14.21 - EPS (TTM)
0.1400 - Earnings Date --
- Forward Dividend & Yield 0.05 (2.31%)
- Ex-Dividend Date Sep 23, 2024
- 1y Target Est
--
Antibiotice S.A. produces and sells medicinal products in Romania. The company produces medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, and suppositories. The company also provides active pharmaceutical ingredient. In addition, it exports its products worldwide. The company was founded in 1955 and is headquartered in Iasi, Romania.
www.antibiotice.ro1,352
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ATB.RO
Performance Overview: ATB.RO
Trailing total returns as of 5/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATB.RO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATB.RO
Valuation Measures
Market Cap
1.34B
Enterprise Value
1.41B
Trailing P/E
13.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.21
Price/Book (mrq)
1.51
Enterprise Value/Revenue
2.34
Enterprise Value/EBITDA
10.06
Financial Highlights
Profitability and Income Statement
Profit Margin
13.18%
Return on Assets (ttm)
5.74%
Return on Equity (ttm)
10.21%
Revenue (ttm)
615.29M
Net Income Avi to Common (ttm)
81.09M
Diluted EPS (ttm)
0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.81M
Total Debt/Equity (mrq)
7.83%
Levered Free Cash Flow (ttm)
-3.11M
Research Analysis: ATB.RO
Company Insights: ATB.RO
ATB.RO does not have Company Insights